aluates Reports

$ 0.0

Automative

Global Radioisotopes in Medicine Market Research Report 2026

Published Date: 2026-06-11

Report Code: QYRE-Auto-24S13607

Global Radioisotopes in Medicine Market Research Report 2023

BUY CHAPTERS

Global Radioisotopes in Medicine Market Research Report 2026

Code: QYRE-Auto-24S13607

Report

2026-06-11

Pages:142

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

NRG

IRE

ANSTO

NTP Radioisotopes

China National Nuclear Corporation

Rosatom

Nordion

Eckert & Ziegler Strahlen

Polatom

SHINE Technologies

NorthStar Medical Radioisotopes

Eckert & Ziegler Strahlen

Radioisotopes in Medicine Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Radioisotopes in Medicine Market

The global Radioisotopes in Medicine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Radioisotopes in Medicine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Nuclear medicine uses radiation to provide diagnostic information about the functioning of a person"s specific organs, or to treat them. Diagnostic procedures using radioisotopes are now routine. Radiotherapy can be used to treat some medical conditions, especially cancer, using radiation to weaken or destroy particular targeted cells. The attributes of naturally decaying atoms, known as radioisotopes, give rise to several applications across many aspects of modern day life. There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report delivers a comprehensive overview of the global Radioisotopes in Medicine market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Radioisotopes in Medicine. The Radioisotopes in Medicine market size, estimates, and forecasts are provided in terms of output/shipments (K Curie) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Radioisotopes in Medicine market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Radioisotopes in Medicine manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Radioisotopes in Medicine Market Report

Report Metric	Details
Report Name	Radioisotopes in Medicine Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Tc-99m Cobalt-60 Iodine Radioisotopes Others
by Application	Nuclear Therapy Equipment Radioactive Source Diagnosis
Production by Region	North America Europe China Japan
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen, Polatom, SHINE Technologies, NorthStar Medical Radioisotopes
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Radioisotopes in Medicine manufacturers, including prices, production, value-based market shares, latest development plans, and information on mergers and acquisitions.
Chapter 3: Examines Radioisotopes in Medicine production/output and value by region and country, providing a quantitative assessment of market size and growth potential for each region over the next six years.
Chapter 4: Analyzes Radioisotopes in Medicine consumption at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national production.
Chapter 5: Analyzes market segments by Type, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 6: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 7: Profiles key players, detailing the fundamentals of major companies, including product production/output, value, price, gross margin, product portfolio/introductions, and recent developments.
Chapter 8: Reviews the industry value chain, including upstream and downstream segments.
Chapter 9: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 10: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Radioisotopes in Medicine Market report?

Ans: The main players in the Radioisotopes in Medicine Market are NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Eckert & Ziegler Strahlen, Polatom, SHINE Technologies, NorthStar Medical Radioisotopes

What are the Application segmentation covered in the Radioisotopes in Medicine Market report?

Ans: The Applications covered in the Radioisotopes in Medicine Market report are Nuclear Therapy, Equipment Radioactive Source, Diagnosis

What are the Type segmentation covered in the Radioisotopes in Medicine Market report?

Ans: The Types covered in the Radioisotopes in Medicine Market report are Tc-99m, Cobalt-60, Iodine Radioisotopes, Others

1 Radioisotopes in Medicine Market Overview

1.1 Product Definition

1.2 Radioisotopes in Medicine by Type

1.2.1 Global Radioisotopes in Medicine Market Value Growth Rate Analysis by Type: 2025 vs 2032

1.2.2 Tc-99m

1.2.3 Cobalt-60

1.2.4 Iodine Radioisotopes

1.2.5 Others

1.3 Radioisotopes in Medicine by Application

1.3.1 Global Radioisotopes in Medicine Market Value Growth Rate Analysis by Application: 2025 vs 2032

1.3.2 Nuclear Therapy

1.3.3 Equipment Radioactive Source

1.3.4 Diagnosis

1.4 Global Market Growth Prospects

1.4.1 Global Radioisotopes in Medicine Production Value Estimates and Forecasts (2021–2032)

1.4.2 Global Radioisotopes in Medicine Production Capacity Estimates and Forecasts (2021–2032)

1.4.3 Global Radioisotopes in Medicine Production Estimates and Forecasts (2021–2032)

1.4.4 Global Radioisotopes in Medicine Market Average Price Estimates and Forecasts (2021–2032)

1.5 Assumptions and Limitations

2 Market Competition by Manufacturers

2.1 Global Radioisotopes in Medicine Production Market Share by Manufacturers (2021–2026)

2.2 Global Radioisotopes in Medicine Production Value Market Share by Manufacturers (2021–2026)

2.3 Global Key Players of Radioisotopes in Medicine, Industry Ranking, 2024 vs 2025

2.4 Global Radioisotopes in Medicine Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.5 Global Radioisotopes in Medicine Average Price by Manufacturers (2021–2026)

2.6 Global Key Manufacturers of Radioisotopes in Medicine, Manufacturing Footprints and Headquarters

2.7 Global Key Manufacturers of Radioisotopes in Medicine, Product Offerings and Applications

2.8 Global Key Manufacturers of Radioisotopes in Medicine, Date of Entry into the Industry

2.9 Radioisotopes in Medicine Market Competitive Situation and Trends

2.9.1 Radioisotopes in Medicine Market Concentration Rate

2.9.2 Top 5 and Top 10 Global Radioisotopes in Medicine Players Market Share by Revenue

2.10 Mergers & Acquisitions and Expansion

3 Radioisotopes in Medicine Production by Region

3.1 Global Radioisotopes in Medicine Production Value Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.2 Global Radioisotopes in Medicine Production Value by Region (2021–2032)

3.2.1 Global Radioisotopes in Medicine Production Value by Region (2021–2026)

3.2.2 Global Forecasted Production Value of Radioisotopes in Medicine by Region (2027–2032)

3.3 Global Radioisotopes in Medicine Production Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

3.4 Global Radioisotopes in Medicine Production Volume by Region (2021–2032)

3.4.1 Global Radioisotopes in Medicine Production by Region (2021–2026)

3.4.2 Global Forecasted Production of Radioisotopes in Medicine by Region (2027–2032)

3.5 Global Radioisotopes in Medicine Market Price Analysis by Region (2021–2026)

3.6 Global Radioisotopes in Medicine Production, Value, and Year-over-Year Growth

3.6.1 North America Radioisotopes in Medicine Production Value Estimates and Forecasts (2021–2032)

3.6.2 Europe Radioisotopes in Medicine Production Value Estimates and Forecasts (2021–2032)

3.6.3 China Radioisotopes in Medicine Production Value Estimates and Forecasts (2021–2032)

3.6.4 Japan Radioisotopes in Medicine Production Value Estimates and Forecasts (2021–2032)

4 Radioisotopes in Medicine Consumption by Region

4.1 Global Radioisotopes in Medicine Consumption Estimates and Forecasts by Region: 2021 vs 2025 vs 2032

4.2 Global Radioisotopes in Medicine Consumption by Region (2021–2032)

4.2.1 Global Radioisotopes in Medicine Consumption by Region (2021–2026)

4.2.2 Global Radioisotopes in Medicine Forecasted Consumption by Region (2027–2032)

4.3 North America

4.3.1 North America Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.3.2 North America Radioisotopes in Medicine Consumption by Country (2021–2032)

4.3.3 U.S.

4.3.4 Canada

4.4 Europe

4.4.1 Europe Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.4.2 Europe Radioisotopes in Medicine Consumption by Country (2021–2032)

4.4.3 Germany

4.4.4 France

4.4.5 U.K.

4.4.6 Italy

4.4.7 Russia

4.5 Asia Pacific

4.5.1 Asia Pacific Radioisotopes in Medicine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032

4.5.2 Asia Pacific Radioisotopes in Medicine Consumption by Region (2021–2032)

4.5.3 China

4.5.4 Japan

4.5.5 South Korea

4.5.6 China Taiwan

4.5.7 Southeast Asia

4.5.8 India

4.6 Latin America, Middle East & Africa

4.6.1 Latin America, Middle East & Africa Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032

4.6.2 Latin America, Middle East & Africa Radioisotopes in Medicine Consumption by Country (2021–2032)

4.6.3 Mexico

4.6.4 Brazil

4.6.5 Turkey

4.6.6 GCC Countries

5 Segment by Type

5.1 Global Radioisotopes in Medicine Production by Type (2021–2032)

5.1.1 Global Radioisotopes in Medicine Production by Type (2021–2026)

5.1.2 Global Radioisotopes in Medicine Production by Type (2027–2032)

5.1.3 Global Radioisotopes in Medicine Production Market Share by Type (2021–2032)

5.2 Global Radioisotopes in Medicine Production Value by Type (2021–2032)

5.2.1 Global Radioisotopes in Medicine Production Value by Type (2021–2026)

5.2.2 Global Radioisotopes in Medicine Production Value by Type (2027–2032)

5.2.3 Global Radioisotopes in Medicine Production Value Market Share by Type (2021–2032)

5.3 Global Radioisotopes in Medicine Price by Type (2021–2032)

6 Segment by Application

6.1 Global Radioisotopes in Medicine Production by Application (2021–2032)

6.1.1 Global Radioisotopes in Medicine Production by Application (2021–2026)

6.1.2 Global Radioisotopes in Medicine Production by Application (2027–2032)

6.1.3 Global Radioisotopes in Medicine Production Market Share by Application (2021–2032)

6.2 Global Radioisotopes in Medicine Production Value by Application (2021–2032)

6.2.1 Global Radioisotopes in Medicine Production Value by Application (2021–2026)

6.2.2 Global Radioisotopes in Medicine Production Value by Application (2027–2032)

6.2.3 Global Radioisotopes in Medicine Production Value Market Share by Application (2021–2032)

6.3 Global Radioisotopes in Medicine Price by Application (2021–2032)

7 Key Companies Profiled

7.1 NRG

7.1.1 NRG Radioisotopes in Medicine Company Information

7.1.2 NRG Radioisotopes in Medicine Product Portfolio

7.1.3 NRG Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.1.4 NRG Main Business and Markets Served

7.1.5 NRG Recent Developments/Updates

7.2 IRE

7.2.1 IRE Radioisotopes in Medicine Company Information

7.2.2 IRE Radioisotopes in Medicine Product Portfolio

7.2.3 IRE Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.2.4 IRE Main Business and Markets Served

7.2.5 IRE Recent Developments/Updates

7.3 ANSTO

7.3.1 ANSTO Radioisotopes in Medicine Company Information

7.3.2 ANSTO Radioisotopes in Medicine Product Portfolio

7.3.3 ANSTO Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.3.4 ANSTO Main Business and Markets Served

7.3.5 ANSTO Recent Developments/Updates

7.4 NTP Radioisotopes

7.4.1 NTP Radioisotopes Radioisotopes in Medicine Company Information

7.4.2 NTP Radioisotopes Radioisotopes in Medicine Product Portfolio

7.4.3 NTP Radioisotopes Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.4.4 NTP Radioisotopes Main Business and Markets Served

7.4.5 NTP Radioisotopes Recent Developments/Updates

7.5 China National Nuclear Corporation

7.5.1 China National Nuclear Corporation Radioisotopes in Medicine Company Information

7.5.2 China National Nuclear Corporation Radioisotopes in Medicine Product Portfolio

7.5.3 China National Nuclear Corporation Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.5.4 China National Nuclear Corporation Main Business and Markets Served

7.5.5 China National Nuclear Corporation Recent Developments/Updates

7.6 Rosatom

7.6.1 Rosatom Radioisotopes in Medicine Company Information

7.6.2 Rosatom Radioisotopes in Medicine Product Portfolio

7.6.3 Rosatom Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.6.4 Rosatom Main Business and Markets Served

7.6.5 Rosatom Recent Developments/Updates

7.7 Nordion

7.7.1 Nordion Radioisotopes in Medicine Company Information

7.7.2 Nordion Radioisotopes in Medicine Product Portfolio

7.7.3 Nordion Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.7.4 Nordion Main Business and Markets Served

7.7.5 Nordion Recent Developments/Updates

7.8 Eckert & Ziegler Strahlen

7.8.1 Eckert & Ziegler Strahlen Radioisotopes in Medicine Company Information

7.8.2 Eckert & Ziegler Strahlen Radioisotopes in Medicine Product Portfolio

7.8.3 Eckert & Ziegler Strahlen Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.8.4 Eckert & Ziegler Strahlen Main Business and Markets Served

7.8.5 Eckert & Ziegler Strahlen Recent Developments/Updates

7.9 Polatom

7.9.1 Polatom Radioisotopes in Medicine Company Information

7.9.2 Polatom Radioisotopes in Medicine Product Portfolio

7.9.3 Polatom Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.9.4 Polatom Main Business and Markets Served

7.9.5 Polatom Recent Developments/Updates

7.10 SHINE Technologies

7.10.1 SHINE Technologies Radioisotopes in Medicine Company Information

7.10.2 SHINE Technologies Radioisotopes in Medicine Product Portfolio

7.10.3 SHINE Technologies Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.10.4 SHINE Technologies Main Business and Markets Served

7.10.5 SHINE Technologies Recent Developments/Updates

7.11 NorthStar Medical Radioisotopes

7.11.1 NorthStar Medical Radioisotopes Radioisotopes in Medicine Company Information

7.11.2 NorthStar Medical Radioisotopes Radioisotopes in Medicine Product Portfolio

7.11.3 NorthStar Medical Radioisotopes Radioisotopes in Medicine Production, Value, Price, and Gross Margin (2021–2026)

7.11.4 NorthStar Medical Radioisotopes Main Business and Markets Served

7.11.5 NorthStar Medical Radioisotopes Recent Developments/Updates

8 Industry Chain and Sales Channels Analysis

8.1 Radioisotopes in Medicine Industry Chain Analysis

8.2 Radioisotopes in Medicine Raw Material Supply Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.3 Radioisotopes in Medicine Production Modes and Processes

8.4 Radioisotopes in Medicine Sales and Marketing

8.4.1 Radioisotopes in Medicine Sales Channels

8.4.2 Radioisotopes in Medicine Distributors

8.5 Radioisotopes in Medicine Customer Analysis

9 Radioisotopes in Medicine Market Dynamics

9.1 Radioisotopes in Medicine Industry Trends

9.2 Radioisotopes in Medicine Market Drivers

9.3 Radioisotopes in Medicine Market Challenges

9.4 Radioisotopes in Medicine Market Restraints

9.5 Impact of U.S. Tariffs

10 Research Findings and Conclusion

11 Methodology and Data Source

11.1 Methodology/Research Approach

11.1.1 Research Programs/Design

11.1.2 Market Size Estimation

11.1.3 Market Breakdown and Data Triangulation

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Author List

11.4 Disclaimer

FEATURED COMPANIES

NRG

IRE

ANSTO

NTP Radioisotopes

China National Nuclear Corporation

Rosatom

Nordion

Eckert & Ziegler Strahlen

Polatom

SHINE Technologies

NorthStar Medical Radioisotopes

Eckert & Ziegler Strahlen

List of Tables

Table 1. Global Radioisotopes in Medicine Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Radioisotopes in Medicine Market Value by Application (US$ Million), 2025 vs 2032

Table 3. Global Radioisotopes in Medicine Production Capacity (K Curie) by Manufacturers in 2025

Table 4. Global Radioisotopes in Medicine Production by Manufacturers (K Curie), 2021–2026

Table 5. Global Radioisotopes in Medicine Production Market Share by Manufacturers (2021–2026)

Table 6. Global Radioisotopes in Medicine Production Value by Manufacturers (US$ Million), 2021–2026

Table 7. Global Radioisotopes in Medicine Production Value Share by Manufacturers (2021–2026)

Table 8. Global Key Players of Radioisotopes in Medicine, Industry Ranking, 2024 vs 2025

Table 9. Classification of Companies by Tier (Tier 1, Tier 2, Tier 3), based on Radioisotopes in Medicine Production Value, 2025

Table 10. Global Market Radioisotopes in Medicine Average Price by Manufacturers (US$/Curie), 2021–2026

Table 11. Global Key Manufacturers of Radioisotopes in Medicine, Manufacturing Footprints and Headquarters

Table 12. Global Key Manufacturers of Radioisotopes in Medicine, Product Offerings and Applications

Table 13. Global Key Manufacturers of Radioisotopes in Medicine, Date of Entry into the Industry

Table 14. Global Radioisotopes in Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 15. Mergers & Acquisitions and Expansion Plans

Table 16. Global Radioisotopes in Medicine Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 17. Global Radioisotopes in Medicine Production Value (US$ Million) by Region (2021–2026)

Table 18. Global Radioisotopes in Medicine Production Value Market Share by Region (2021–2026)

Table 19. Global Radioisotopes in Medicine Production Value (US$ Million) Forecast by Region (2027–2032)

Table 20. Global Radioisotopes in Medicine Production Value Market Share Forecast by Region (2027–2032)

Table 21. Global Radioisotopes in Medicine Production Comparison by Region: 2021 vs 2025 vs 2032 (K Curie)

Table 22. Global Radioisotopes in Medicine Production (K Curie) by Region (2021–2026)

Table 23. Global Radioisotopes in Medicine Production Market Share by Region (2021–2026)

Table 24. Global Radioisotopes in Medicine Production (K Curie) Forecast by Region (2027–2032)

Table 25. Global Radioisotopes in Medicine Production Market Share Forecast by Region (2027–2032)

Table 26. Global Radioisotopes in Medicine Market Average Price (US$/Curie) by Region (2021–2026)

Table 27. Global Radioisotopes in Medicine Market Average Price (US$/Curie) by Region (2027–2032)

Table 28. Global Radioisotopes in Medicine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Curie)

Table 29. Global Radioisotopes in Medicine Consumption by Region (K Curie), 2021–2026

Table 30. Global Radioisotopes in Medicine Consumption Market Share by Region (2021–2026)

Table 31. Global Radioisotopes in Medicine Forecasted Consumption by Region (K Curie), 2027–2032

Table 32. Global Radioisotopes in Medicine Forecasted Consumption Market Share by Region (2027–2032)

Table 33. North America Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Curie)

Table 34. North America Radioisotopes in Medicine Consumption by Country (K Curie), 2021–2026

Table 35. North America Radioisotopes in Medicine Consumption by Country (K Curie), 2027–2032

Table 36. Europe Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Curie)

Table 37. Europe Radioisotopes in Medicine Consumption by Country (K Curie), 2021–2026

Table 38. Europe Radioisotopes in Medicine Consumption by Country (K Curie), 2027–2032

Table 39. Asia Pacific Radioisotopes in Medicine Consumption Growth Rate by Region: 2021 vs 2025 vs 2032 (K Curie)

Table 40. Asia Pacific Radioisotopes in Medicine Consumption by Region (K Curie), 2021–2026

Table 41. Asia Pacific Radioisotopes in Medicine Consumption by Region (K Curie), 2027–2032

Table 42. Latin America, Middle East & Africa Radioisotopes in Medicine Consumption Growth Rate by Country: 2021 vs 2025 vs 2032 (K Curie)

Table 43. Latin America, Middle East & Africa Radioisotopes in Medicine Consumption by Country (K Curie), 2021–2026

Table 44. Latin America, Middle East & Africa Radioisotopes in Medicine Consumption by Country (K Curie), 2027–2032

Table 45. Global Radioisotopes in Medicine Production (K Curie) by Type (2021–2026)

Table 46. Global Radioisotopes in Medicine Production (K Curie) by Type (2027–2032)

Table 47. Global Radioisotopes in Medicine Production Market Share by Type (2021–2026)

Table 48. Global Radioisotopes in Medicine Production Market Share by Type (2027–2032)

Table 49. Global Radioisotopes in Medicine Production Value (US$ Million) by Type (2021–2026)

Table 50. Global Radioisotopes in Medicine Production Value (US$ Million) by Type (2027–2032)

Table 51. Global Radioisotopes in Medicine Production Value Market Share by Type (2021–2026)

Table 52. Global Radioisotopes in Medicine Production Value Market Share by Type (2027–2032)

Table 53. Global Radioisotopes in Medicine Price (US$/Curie) by Type (2021–2026)

Table 54. Global Radioisotopes in Medicine Price (US$/Curie) by Type (2027–2032)

Table 55. Global Radioisotopes in Medicine Production (K Curie) by Application (2021–2026)

Table 56. Global Radioisotopes in Medicine Production (K Curie) by Application (2027–2032)

Table 57. Global Radioisotopes in Medicine Production Market Share by Application (2021–2026)

Table 58. Global Radioisotopes in Medicine Production Market Share by Application (2027–2032)

Table 59. Global Radioisotopes in Medicine Production Value (US$ Million) by Application (2021–2026)

Table 60. Global Radioisotopes in Medicine Production Value (US$ Million) by Application (2027–2032)

Table 61. Global Radioisotopes in Medicine Production Value Market Share by Application (2021–2026)

Table 62. Global Radioisotopes in Medicine Production Value Market Share by Application (2027–2032)

Table 63. Global Radioisotopes in Medicine Price (US$/Curie) by Application (2021–2026)

Table 64. Global Radioisotopes in Medicine Price (US$/Curie) by Application (2027–2032)

Table 65. NRG Radioisotopes in Medicine Company Information

Table 66. NRG Radioisotopes in Medicine Specification and Application

Table 67. NRG Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 68. NRG Main Business and Markets Served

Table 69. NRG Recent Developments/Updates

Table 70. IRE Radioisotopes in Medicine Company Information

Table 71. IRE Radioisotopes in Medicine Specification and Application

Table 72. IRE Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 73. IRE Main Business and Markets Served

Table 74. IRE Recent Developments/Updates

Table 75. ANSTO Radioisotopes in Medicine Company Information

Table 76. ANSTO Radioisotopes in Medicine Specification and Application

Table 77. ANSTO Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 78. ANSTO Main Business and Markets Served

Table 79. ANSTO Recent Developments/Updates

Table 80. NTP Radioisotopes Radioisotopes in Medicine Company Information

Table 81. NTP Radioisotopes Radioisotopes in Medicine Specification and Application

Table 82. NTP Radioisotopes Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 83. NTP Radioisotopes Main Business and Markets Served

Table 84. NTP Radioisotopes Recent Developments/Updates

Table 85. China National Nuclear Corporation Radioisotopes in Medicine Company Information

Table 86. China National Nuclear Corporation Radioisotopes in Medicine Specification and Application

Table 87. China National Nuclear Corporation Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 88. China National Nuclear Corporation Main Business and Markets Served

Table 89. China National Nuclear Corporation Recent Developments/Updates

Table 90. Rosatom Radioisotopes in Medicine Company Information

Table 91. Rosatom Radioisotopes in Medicine Specification and Application

Table 92. Rosatom Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 93. Rosatom Main Business and Markets Served

Table 94. Rosatom Recent Developments/Updates

Table 95. Nordion Radioisotopes in Medicine Company Information

Table 96. Nordion Radioisotopes in Medicine Specification and Application

Table 97. Nordion Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 98. Nordion Main Business and Markets Served

Table 99. Nordion Recent Developments/Updates

Table 100. Eckert & Ziegler Strahlen Radioisotopes in Medicine Company Information

Table 101. Eckert & Ziegler Strahlen Radioisotopes in Medicine Specification and Application

Table 102. Eckert & Ziegler Strahlen Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 103. Eckert & Ziegler Strahlen Main Business and Markets Served

Table 104. Eckert & Ziegler Strahlen Recent Developments/Updates

Table 105. Polatom Radioisotopes in Medicine Company Information

Table 106. Polatom Radioisotopes in Medicine Specification and Application

Table 107. Polatom Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 108. Polatom Main Business and Markets Served

Table 109. Polatom Recent Developments/Updates

Table 110. SHINE Technologies Radioisotopes in Medicine Company Information

Table 111. SHINE Technologies Radioisotopes in Medicine Specification and Application

Table 112. SHINE Technologies Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 113. SHINE Technologies Main Business and Markets Served

Table 114. SHINE Technologies Recent Developments/Updates

Table 115. NorthStar Medical Radioisotopes Radioisotopes in Medicine Company Information

Table 116. NorthStar Medical Radioisotopes Radioisotopes in Medicine Specification and Application

Table 117. NorthStar Medical Radioisotopes Radioisotopes in Medicine Production (K Curie), Value (US$ Million), Price (US$/Curie) and Gross Margin (2021–2026)

Table 118. NorthStar Medical Radioisotopes Main Business and Markets Served

Table 119. NorthStar Medical Radioisotopes Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Radioisotopes in Medicine Distributors List

Table 123. Radioisotopes in Medicine Customers List

Table 124. Radioisotopes in Medicine Market Trends

Table 125. Radioisotopes in Medicine Market Drivers

Table 126. Radioisotopes in Medicine Market Challenges

Table 127. Radioisotopes in Medicine Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Radioisotopes in Medicine

Figure 2. Global Radioisotopes in Medicine Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Radioisotopes in Medicine Market Share by Type: 2025 vs 2032

Figure 4. Tc-99m Product Picture

Figure 5. Cobalt-60 Product Picture

Figure 6. Iodine Radioisotopes Product Picture

Figure 7. Others Product Picture

Figure 8. Global Radioisotopes in Medicine Market Value by Application (US$ Million), 2021–2032

Figure 9. Global Radioisotopes in Medicine Market Share by Application: 2025 vs 2032

Figure 10. Nuclear Therapy

Figure 11. Equipment Radioactive Source

Figure 12. Diagnosis

Figure 13. Global Radioisotopes in Medicine Production Value (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Radioisotopes in Medicine Production Value (US$ Million), 2021–2032

Figure 15. Global Radioisotopes in Medicine Production Capacity (K Curie), 2021–2032

Figure 16. Global Radioisotopes in Medicine Production (K Curie), 2021–2032

Figure 17. Global Radioisotopes in Medicine Average Price (US$/Curie), 2021–2032

Figure 18. Radioisotopes in Medicine Report Years Considered

Figure 19. Radioisotopes in Medicine Production Share by Manufacturers in 2025

Figure 20. Global Radioisotopes in Medicine Production Value Share by Manufacturers (2025)

Figure 21. Radioisotopes in Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 22. Top 5 and Top 10 Global Players: Market Share by Radioisotopes in Medicine Revenue in 2025

Figure 23. Global Radioisotopes in Medicine Production Value by Region: 2021 vs 2025 vs 2032 (US$ Million)

Figure 24. Global Radioisotopes in Medicine Production Value Market Share by Region: 2021 vs 2025 vs 2032

Figure 25. Global Radioisotopes in Medicine Production Comparison by Region: 2021 vs 2025 vs 2032 (K Curie)

Figure 26. Global Radioisotopes in Medicine Production Market Share by Region: 2021 vs 2025 vs 2032

Figure 27. North America Radioisotopes in Medicine Production Value (US$ Million) Growth Rate (2021–2032)

Figure 28. Europe Radioisotopes in Medicine Production Value (US$ Million) Growth Rate (2021–2032)

Figure 29. China Radioisotopes in Medicine Production Value (US$ Million) Growth Rate (2021–2032)

Figure 30. Japan Radioisotopes in Medicine Production Value (US$ Million) Growth Rate (2021–2032)

Figure 31. Global Radioisotopes in Medicine Consumption by Region: 2021 vs 2025 vs 2032 (K Curie)

Figure 32. Global Radioisotopes in Medicine Consumption Market Share by Region: 2021 vs 2025 vs 2032

Figure 33. North America Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 34. North America Radioisotopes in Medicine Consumption Market Share by Country (2021–2032)

Figure 35. U.S. Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 36. Canada Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 37. Europe Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 38. Europe Radioisotopes in Medicine Consumption Market Share by Country (2021–2032)

Figure 39. Germany Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 40. France Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 41. U.K. Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 42. Italy Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 43. Russia Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 44. Asia Pacific Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 45. Asia Pacific Radioisotopes in Medicine Consumption Market Share by Region (2021–2032)

Figure 46. China Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 47. Japan Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 48. South Korea Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 49. China Taiwan Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 50. Southeast Asia Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 51. India Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 52. Latin America, Middle East & Africa Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 53. Latin America, Middle East & Africa Radioisotopes in Medicine Consumption Market Share by Country (2021–2032)

Figure 54. Mexico Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 55. Brazil Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 56. Turkey Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 57. GCC Countries Radioisotopes in Medicine Consumption and Growth Rate (K Curie), 2021–2032

Figure 58. Global Production Market Share of Radioisotopes in Medicine by Type (2021–2032)

Figure 59. Global Production Value Market Share of Radioisotopes in Medicine by Type (2021–2032)

Figure 60. Global Radioisotopes in Medicine Price (US$/Curie) by Type (2021–2032)

Figure 61. Global Production Market Share of Radioisotopes in Medicine by Application (2021–2032)

Figure 62. Global Production Value Market Share of Radioisotopes in Medicine by Application (2021–2032)

Figure 63. Global Radioisotopes in Medicine Price (US$/Curie) by Application (2021–2032)

Figure 64. Radioisotopes in Medicine Value Chain

Figure 65. Channels of Distribution (Direct Vs Distribution)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Nuclear Medicine Radioisotopes Market Insights Forecast to 2030

Global Radioisotopes for Nuclear Medicine Diagnosis and Treatment Market Research Report 2024

Nuclear Medicine Isotopes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nuclear Medicine Market Research Report 2025

Nuclear Medicine Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Medical Radioactive Isotopes Market Research Report 2025

Radioisotope Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic Radioisotopes Market Insights Forecast to 2030

Global Radioactive Therapeutic Drugs Market Research Report 2024

Global Nuclear Medicine Radiopharmaceuticals Market Research Report 2024

Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025

Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030

Global Radiopharmaceutical Therapy Market Research Report 2025

Global Diagnostic Radioisotopes Market Insights Forecast to 2030

Nuclear Medicine Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nuclear Medicine Science Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nuclear Medicine System Market Insights Forecast to 2030

Global Prostate Cancer Nuclear Medicine Diagnostics Market Insights Forecast to 2030

Global Radiopharmaceutical Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions